A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)

NCT07450053 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Short Stature

Interventions

DRUG: GenSci134 Injection
DRUG: Recombinant Human Growth Hormone Injection(Norditropin® FlexPro®)

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.